Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2026 Filed Jun 15, 2026 21:00 UTC |
Whalen Matthew PrattDirector
|
GrantStock Options (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001493152-26-028715 · ownership.xml · derivative · entry 1 Whalen Matthew Pratt · CIK 0002033867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-06-12 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 21:00 UTC |
Shekhat Denil NanjiDirector
|
GrantStock Options (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001493152-26-028714 · ownership.xml · derivative · entry 1 Shekhat Denil Nanji · CIK 0002016605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-06-12 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 21:00 UTC |
Del Giudice Matthew PaulDirector
|
GrantStock Options (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001493152-26-028712 · ownership.xml · derivative · entry 1 Del Giudice Matthew Paul · CIK 0002016630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-06-12 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 21:00 UTC |
MacPherson Edward CloustonDirector
|
GrantStock Options (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001493152-26-028713 · ownership.xml · derivative · entry 1 MacPherson Edward Clouston · CIK 0002015989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-06-12 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 21:00 UTC |
Aminov ErezDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 83,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-014697 · ownership.xml · derivative · entry 1 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,500 Underlying: Common Stock · 83,500 shares Expires 2036-03-30 F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: The RSUs were issued to the Reporting Person on the Grant Date, pursuant to the Plan. All of the RSU shall vested on the Grant Date. Read SEC document |
| December 17, 2025 Filed Feb 18, 2026 01:30 UTC |
Aminov ErezDirector · CEO and Chairman
|
GrantStock Options (right to buy) · Derivative | 3,155,170 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001493152-26-007226 · ownership.xml · derivative · entry 8 Aminov Erez · CIK 0001986112 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,155,170 Underlying: Common Stock · 3,155,170 shares Expires 2035-12-17 F1 · derivative.exercise_price: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4. F5 · kind: Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance. F5 · shares: Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance. F5 · derivative.exercise_date: Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance. F5 · derivative.underlying_shares: Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance. Read SEC document |
| October 16, 2025 Filed Feb 18, 2026 01:30 UTC |
Aminov ErezDirector · CEO and Chairman
|
Exercise / conversionStock Options (right to buy) · Derivative | 379,000 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001493152-26-007226 · ownership.xml · derivative · entry 7 Aminov Erez · CIK 0001986112 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,000 Underlying: Common Stock · 379,000 shares Expires 2034-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents exercise of 379,000 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.84 each. Read SEC document |
| October 16, 2025 Filed Feb 18, 2026 01:30 UTC |
Aminov ErezDirector · CEO and Chairman
|
Exercise / conversionStock Options (right to buy) · Derivative | 234,595 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001493152-26-007226 · ownership.xml · derivative · entry 6 Aminov Erez · CIK 0001986112 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,595 Underlying: Common Stock · Not disclosed shares Expires 2034-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents exercise of 234,595 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on March 26, 2024, with 50% of such options vesting on the six-month anniversary date of the grant, and the remaining half vesting on the one-year anniversary date of the grant, pursuant to a grant under the Plan at an exercise price of $1.16 each. Read SEC document |
| October 16, 2025 Filed Feb 18, 2026 01:30 UTC |
Aminov ErezDirector · CEO and Chairman
|
SaleCommon Stock | 613,595 | $2.11 | $1,294,685.45 |
DisclosureSEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 5 Aminov Erez · CIK 0001986112 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,592,666 F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4. Read SEC document |
| October 16, 2025 Filed Feb 18, 2026 01:30 UTC |
Aminov ErezDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 379,000 | $0.84 | $318,360.00 |
DisclosureSEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 4 Aminov Erez · CIK 0001986112 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,206,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4. F4 · kind: Represents exercise of 379,000 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.84 each. F4 · price: Represents exercise of 379,000 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.84 each. Read SEC document |
| October 16, 2025 Filed Feb 18, 2026 01:30 UTC |
Aminov ErezDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 234,595 | $1.16 | $272,130.20 |
DisclosureSEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 3 Aminov Erez · CIK 0001986112 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,827,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4. F3 · kind: Represents exercise of 234,595 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on March 26, 2024, with 50% of such options vesting on the six-month anniversary date of the grant, and the remaining half vesting on the one-year anniversary date of the grant, pursuant to a grant under the Plan at an exercise price of $1.16 each. F3 · price: Represents exercise of 234,595 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on March 26, 2024, with 50% of such options vesting on the six-month anniversary date of the grant, and the remaining half vesting on the one-year anniversary date of the grant, pursuant to a grant under the Plan at an exercise price of $1.16 each. Read SEC document |
| October 01, 2025 Filed Oct 4, 2025 00:00 UTC |
Shekhat Denil NanjiDirector
|
GrantCommon Stock | 22,378 | $1.35 | $30,210.30 |
DisclosureSEC source: 0001493152-25-016958 · ownership.xml · nonDerivative · entry 1 Shekhat Denil Nanji · CIK 0002016605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,378 F1 · security: Represents 22,378 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc. F1 · price: Represents 22,378 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc. Read SEC document |
| October 01, 2025 Filed Oct 4, 2025 00:00 UTC |
Aminov ErezDirector · Chief Executive Officer
|
GrantCommon Stock | 2,685,456 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-016957 · ownership.xml · nonDerivative · entry 1 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,530,156 F1 · security: Represents 2,685,456 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc. F1 · price: Represents 2,685,456 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc. Read SEC document |
| September 18, 2025 Filed Sep 19, 2025 00:00 UTC |
Aminov ErezDirector · Chief Executive Officer
|
GrantStock Options (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-25-014114 · ownership.xml · derivative · entry 2 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-08-17 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on September 15, 2025. F4 · kind: The board of directors of the Company approved to reprice the options from its previous exercise price of $6.50 to $1.38. All of the other terms of the option remain unchanged. F5 · shares: The options were previously issued to the Reporting Person on August 17, 2023, and are now fully vested. F2 · derivative.exercise_date: The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged. F5 · derivative.underlying_shares: The options were previously issued to the Reporting Person on August 17, 2023, and are now fully vested. Read SEC document |
| September 18, 2025 Filed Sep 19, 2025 00:00 UTC |
Aminov ErezDirector · Chief Executive Officer
|
GrantStock Options (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-25-014114 · ownership.xml · derivative · entry 1 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-04-28 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on September 15, 2025. F2 · kind: The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged. F3 · shares: The options were previously issued to the Reporting Person on April 28, 2023, and are now fully vested. F2 · derivative.exercise_date: The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged. F3 · derivative.underlying_shares: The options were previously issued to the Reporting Person on April 28, 2023, and are now fully vested. Read SEC document |
| August 29, 2025 Filed Sep 3, 2025 20:05 UTC |
Aminov ErezDirector · Chief Executive Officer
|
GrantCommon Stock | 62,500 | $1.37 | $85,625.00 |
DisclosureSEC source: 0001641172-25-026388 · ownership.xml · nonDerivative · entry 1 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 844,700 F1 · security: Represents 62,500 RSUs vesting immediately, granted and issued to the Reporting Person from the Issuer's 2022 Omnibus Incentive Plan in connection with the Reporting Person's achievement of certain milestones pursuant to the Reporting Person's Executive Incentive Compensation Plan. Read SEC document |
| March 26, 2025 Filed Feb 18, 2026 01:30 UTC |
Aminov ErezDirector · CEO and Chairman
|
GrantCommon Stock | 62,500 | $1.45 | $90,625.00 |
DisclosureSEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 2 Aminov Erez · CIK 0001986112 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,592,666 F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4. F2 · kind: Represents grants of RSUs with underlying shares of Common Stock under the Issuer's 2024 Omnibus Equity Incentive Plan (the "Plan"), for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The RSUs hereunder vested upon issuance. Read SEC document |
| March 26, 2025 Filed Feb 18, 2026 01:30 UTC |
Aminov ErezDirector · CEO and Chairman
|
GrantCommon Stock | 62,500 | $1.45 | $90,625.00 |
DisclosureSEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 1 Aminov Erez · CIK 0001986112 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,530,166 F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4. F2 · kind: Represents grants of RSUs with underlying shares of Common Stock under the Issuer's 2024 Omnibus Equity Incentive Plan (the "Plan"), for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The RSUs hereunder vested upon issuance. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 22:15 UTC |
Whalen Matthew PrattDirector
|
GrantStock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001493152-24-049507 · ownership.xml · derivative · entry 1 Whalen Matthew Pratt · CIK 0002033867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-12-09 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. F3 · balance_after: 25,000 stock options were issued to the Reporting Person on the Grant Date, pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 22:15 UTC |
Shekhat Denil NanjiDirector
|
GrantStock Options (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001493152-24-049506 · ownership.xml · derivative · entry 1 Shekhat Denil Nanji · CIK 0002016605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-12-09 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on December 6, 2024, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $1.19 each. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 22:15 UTC |
Del Giudice Matthew PaulDirector
|
GrantStock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001493152-24-049504 · ownership.xml · derivative · entry 1 Del Giudice Matthew Paul · CIK 0002016630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 25,000 shares Expires 2034-12-09 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. F3 · balance_after: Represents 25,000 stock options that were issued to the Reporting Person on December 6, 2024, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $1.19 each. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 22:15 UTC |
MacPherson Edward CloustonDirector
|
GrantStock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001493152-24-049505 · ownership.xml · derivative · entry 1 MacPherson Edward Clouston · CIK 0002015989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-12-09 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. F3 · balance_after: Represents 25,000 stock options that were issued to the Reporting Person on December 6, 2024, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $1.19 each. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 22:15 UTC |
Yanez MichelleChief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001493152-24-049508 · ownership.xml · derivative · entry 1 Yanez Michelle · CIK 0001958023 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-12-09 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. F3 · balance_after: Represents 150,000 stock options that were issued to the Reporting Person on December 6, 2024, that vest in equal halves on the six- and 12-month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $1.19 each. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 22:15 UTC |
Aminov ErezDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-049503 · ownership.xml · derivative · entry 2 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2034-12-09 F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F5 · derivative.exercise_date: The RSUs were issued to the Reporting Person on the Grant Date, pursuant to the Plan. Half of the shares subject to the RSU shall vest on the Grant Date and the remaining half of the shares subject to the RSU shall vest six months after the Grant Date. F6 · balance_after: Represents 500,000 RSUs that were issued to the Reporting Person on December 6, 2024 under the Plan. Half of the shares subject to the RSU shall vest on the Grant Date and the remaining half of the shares subject to the RSU shall vest six months after the Grant Date. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 22:15 UTC |
Aminov ErezDirector · Chief Executive Officer
|
GrantStock Options (right to buy) · Derivative | 2,000,000 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001493152-24-049503 · ownership.xml · derivative · entry 1 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2034-12-09 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). Half of the shares subject to the option shall vest on the Grant Date and the remaining half of the shares subject to the option shall vest six months after the Grant Date. F3 · balance_after: Represents 2,000,000 stock options that were issued to the Reporting Person on December 6, 2024 under the Plan. Half of the shares subject to the option shall vest on the Grant Date and the remaining half of the shares subject to the option shall vest six months after the Grant Date. Read SEC document |
| November 20, 2024 Filed Nov 27, 2024 21:15 UTC |
Aminov ErezDirector · Chief Executive Officer
|
SaleCommon Stock | 44,590 | $1.27 | $56,629.30 |
DisclosureSEC source: 0001493152-24-047998 · ownership.xml · nonDerivative · entry 2 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,061,200 F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. Read SEC document |
| November 19, 2024 Filed Nov 27, 2024 21:15 UTC |
Aminov ErezDirector · Chief Executive Officer
|
SaleCommon Stock | 55,410 | $1.39 | $77,019.90 |
DisclosureSEC source: 0001493152-24-047998 · ownership.xml · nonDerivative · entry 1 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,105,790 F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 20:05 UTC |
McNulty Brian Patrick10% owner
Bay Shore Trust10% owner
|
SaleCommon Stock | 200,000 | $1.96 | $392,000.00 |
DisclosureSEC source: 0001493152-24-034584 · ownership.xml · nonDerivative · entry 1 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,540,270 F1 · ownership.nature: As trustee of the Bay Shore Trust and the Celeste J Williams Lifetime QTIP Trust, Mr. McNulty has sole voting and dispositive power over the shares held by each trust, and, as a result is deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities held by the trusts. The address for the Bay Shore Trust is 900 West Platt Street, Suite 200, Tampa, Florida, 33606. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 20:30 UTC |
Shekhat Denil NanjiDirector
|
GrantNonqualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001493152-24-024753 · ownership.xml · derivative · entry 1 Shekhat Denil Nanji · CIK 0002016605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,666 Underlying: Common Stock · 50,000 shares Expires 2034-06-18 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the Nasdaq Official Closing Price of the Issuer's common stock on June 18, 2024, the date of the grant. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 18, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"), and in accordance with the terms of a consulting agreement dated June 18, 2024, by and between the Reporting Person and MIRA Pharmaceuticals, Inc. The stock options will vest in three equal tranches, with the first tranche vesting immediately on the grant date of June 18, 2024, the second tranche vesting on December 18, 2024, and the final tranche vesting on June 18, 2025. F3 · balance_after: Represents (i) 25,000 stock options that were issued to the Reporting person on March 25, 2024, that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $1.16 each and (ii) 16,666 stock options that were issued to the Reporting Person on June 18, 2024, that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.71 each. Read SEC document |
| May 28, 2024 Filed May 30, 2024 22:00 UTC |
Aminov ErezDirector · Chief Executive Officer
|
GrantIncentive Stock Options (right to buy) · Derivative | 379,000 | $0.00 Strike: $0.84 | $0.00 |
DisclosureSEC source: 0001493152-24-022029 · ownership.xml · derivative · entry 1 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 629,000 Underlying: Common Stock · 379,000 shares Expires 2034-05-28 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on May 28, 2024. F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on May 28, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). The stock options vested in full and became exercisable immediately upon issuance on the grant date, May 28, 2024. F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on April 28, 2023 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $5.00 each, (ii) 150,000 stock options that were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each, (iii) 50,000 stock options that were issued to the Reporting Person on August 17, 2023 that vested in full and became exercisable on April 28, 2024, pursuant to a grant under the Issuer's Plan at an exercise price of $6.50 each, and (iv) 379,000 stock options that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $0.84 each. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:42 UTC |
Aminov ErezDirector · Chief Executive Officer
|
PurchaseCommon Stock | 800 | $0.97 | $776.00 |
DisclosureSEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 8 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,200 F1 · ownership.direct: These securities are directly owned by Mr. Aminov. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:42 UTC |
Aminov ErezDirector · Chief Executive Officer
|
PurchaseCommon Stock | 800 | $1.01 | $808.00 |
DisclosureSEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 7 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,400 F1 · ownership.direct: These securities are directly owned by Mr. Aminov. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:42 UTC |
Aminov ErezDirector · Chief Executive Officer
|
PurchaseCommon Stock | 600 | $0.87 | $522.00 |
DisclosureSEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 6 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,600 F1 · ownership.direct: These securities are directly owned by Mr. Aminov. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:42 UTC |
Aminov ErezDirector · Chief Executive Officer
|
PurchaseCommon Stock | 1,000 | $0.85 | $850.00 |
DisclosureSEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 5 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,000 F1 · ownership.direct: These securities are directly owned by Mr. Aminov. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:42 UTC |
Aminov ErezDirector · Chief Executive Officer
|
PurchaseCommon Stock | 2,000 | $0.84 | $1,680.00 |
DisclosureSEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 4 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,000 F1 · ownership.direct: These securities are directly owned by Mr. Aminov. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:42 UTC |
Aminov ErezDirector · Chief Executive Officer
|
PurchaseCommon Stock | 500 | $1.02 | $510.00 |
DisclosureSEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 3 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 377,000 F1 · ownership.direct: These securities are directly owned by Mr. Aminov. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:42 UTC |
Aminov ErezDirector · Chief Executive Officer
|
PurchaseCommon Stock | 1,000 | $1.03 | $1,030.00 |
DisclosureSEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 2 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 376,500 F1 · ownership.direct: These securities are directly owned by Mr. Aminov. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:42 UTC |
Aminov ErezDirector · Chief Executive Officer
|
PurchaseCommon Stock | 2,000 | $1.00 | $2,000.00 |
DisclosureSEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 1 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,500 F1 · ownership.direct: These securities are directly owned by Mr. Aminov. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:53 UTC |
Aminov ErezDirector · Chief Executive Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001493152-24-011573 · ownership.xml · derivative · entry 1 Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 300,000 shares Expires 2034-03-26 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on March 26, 2024. F2 · derivative.exercise_date: The options were granted under the Issuer's 2022 Amended and Restated Omnibus Incentive Plan (the "Plan") whereby 50% of such incentive options, or 150,000 options, will vest on the six month anniversary of the of the grant, or September 26, 2024, and the remaining 50% will vest on the first anniversary of the grant date, March 26, 2025. F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on April 28, 2023 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $5.00 each, (ii) 150,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17,2023 at an exercise price of $6.50 each and (iii) 50,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which will vest in full on April 28. 2024 at an exercise price of $6.50 each. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 21:53 UTC |
Yanez MichelleChief Financial Officer
|
GrantIncentive Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001493152-24-011574 · ownership.xml · derivative · entry 1 Yanez Michelle · CIK 0001958023 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,799 Underlying: Common Stock · 150,000 shares Expires 2034-03-26 F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on March 26, 2024. F2 · derivative.exercise_date: The options were granted under the Issuer's 2022 Amended and Restated Omnibus Incentive Plan (the "Plan") whereby 50% of such incentive options, or 75,000 options, will vest on the six month anniversary of the of the grant, or September 26, 2024, and the remaining 50% will vest on the first anniversary of the grant date, March 26, 2025. F3 · balance_after: Represents (i) 3,334 stock options that were issued to the Reporting Person under the Plan that became exercisable on June 15, 2022 at an exercise price of $5.00 (ii) 3,333 stock options that were issued to the Reporting Person under the Plan that became exercise on June 15, 2023 at an exercise price of $5.00 each, (iii) 15,566 stock options were issued to the Reporting Person on April 28, 2023, pursuant to a grant under the Issuer's Plan which vested in full on April 28, 2024 at an exercise price of $6.50 each, (iv) 15,566 stock options were issued to the Reporting Person on April 28, 2023, pursuant to a grant under the Issuer's Plan which will vest in full on April 28, 2024 at an exercise price of $6.50 each (v) 20,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 21:53 UTC |
Shekhat Denil NanjiDirector
|
GrantNonqualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001493152-24-011572 · ownership.xml · derivative · entry 1 Shekhat Denil Nanji · CIK 0002016605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 50,000 shares Expires 2034-03-25 F1 · derivative.exercise_date: The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 21:53 UTC |
Del Giudice Matthew PaulDirector
|
GrantNonqualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001493152-24-011570 · ownership.xml · derivative · entry 1 Del Giudice Matthew Paul · CIK 0002016630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 50,000 shares Expires 2034-03-25 F1 · derivative.exercise_date: The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 21:53 UTC |
MacPherson Edward CloustonDirector
|
GrantNonqualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001493152-24-011569 · ownership.xml · derivative · entry 1 MacPherson Edward Clouston · CIK 0002015989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 50,000 shares Expires 2034-03-25 F1 · derivative.exercise_date: The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 21:53 UTC |
Jerman Michael AllenDirector
|
GrantNonqualified Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001493152-24-011571 · ownership.xml · derivative · entry 1 Jerman Michael Allen · CIK 0001979732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 50,000 shares Expires 2034-03-25 F1 · derivative.exercise_date: The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025. Read SEC document |
| December 11, 2023 Filed Dec 27, 2023 22:33 UTC |
McNulty Brian Patrick10% owner
Bay Shore Trust10% owner
|
SaleCommon Stock | 23,002 | $1.55 | $35,747.41 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 22 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 660,000 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 11, 2023 Filed Dec 27, 2023 22:33 UTC |
McNulty Brian Patrick10% owner
Bay Shore Trust10% owner
|
SaleCommon Stock | 23,003 | $1.55 | $35,748.96 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 11 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,740,270 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 08, 2023 Filed Dec 27, 2023 22:33 UTC |
McNulty Brian Patrick10% owner
Bay Shore Trust10% owner
|
SaleCommon Stock | 9,527 | $1.61 | $15,317.51 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 21 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 683,002 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 08, 2023 Filed Dec 27, 2023 22:33 UTC |
McNulty Brian Patrick10% owner
Bay Shore Trust10% owner
|
SaleCommon Stock | 9,526 | $1.61 | $15,315.90 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 10 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,763,273 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 07, 2023 Filed Dec 27, 2023 22:33 UTC |
McNulty Brian Patrick10% owner
Bay Shore Trust10% owner
|
SaleCommon Stock | 16,667 | $1.89 | $31,578.96 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 20 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 692,529 F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
| December 07, 2023 Filed Dec 27, 2023 22:33 UTC |
McNulty Brian Patrick10% owner
Bay Shore Trust10% owner
|
SaleCommon Stock | 16,666 | $1.89 | $31,577.07 |
DisclosureSEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 9 McNulty Brian Patrick · CIK 0001996353 · 10% owner Bay Shore Trust · CIK 0001986593 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 2,772,799 F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.